With acute diseases, such as acute phase after myocardial infarction (within 3 months), within 3 months after acute heart failure or new cerebral infarction;
In the list of heart transplantation;
Expected survival less than 1 year;
With other hemorrhagic diseases and anticoagulant therapy is not allowed;
Thrombosis in left atrium;
Heart failure, New York Heart Association(NYHA) III/IV or eject fraction(EF)<40%;
Patients with uncontrolled cancer;
Significant hepatic or renal impairment (and/or alanine transaminase(ALT) or Aspartate transaminase(AST) >2 times upper limit of normal, creatinine clearance rate(CCr)<50%);
Previous catheter radiofrequency ablation for AF or cardiac surgery;
Pregnant and lactating women, women who plan to become pregnant, or women of child bearing age not using reliable contraceptive measures.
